|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,227.50 GBX | +1.99% |
|
+2.68% | +22.01% |
| 07:50am | GSK's Exdensur Approved in EU as Add-on Treatment for Severe Asthma, Chronic Rhinosinusitis | MT |
| 07:47am | GSK Begins Up to GBP450 Million Share Buyback Tranche | MT |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.99% | +2.68% | +22.58% | +23.70% | +22.01% | +56.82% | +49.98% | +39.52% | +25.06% | 119B | |
| +0.17% | -0.45% | +0.15% | +1.44% | -3.23% | +23.18% | +218.95% | +405.44% | +1,318.25% | 929B | |
| -0.45% | +2.02% | +11.34% | +24.25% | +17.64% | +55.91% | +53.85% | +47.48% | +137.93% | 587B | |
| +1.76% | +3.69% | +8.00% | -0.37% | +1.32% | +20.03% | +54.82% | +122.17% | +332.63% | 409B | |
| +1.23% | +3.96% | +5.25% | +27.09% | +11.21% | +24.02% | +30.73% | +18.47% | +45.42% | 375B | |
| +0.71% | +7.46% | +9.58% | +11.98% | +10.37% | +29.93% | +32.51% | +105.09% | +255.65% | 320B | |
| +1.19% | +5.54% | +10.51% | +20.72% | +16.51% | +33.38% | +59.05% | +58.04% | +75.41% | 314B | |
| +1.82% | +3.20% | +11.56% | +30.66% | +15.34% | +46.26% | +13.99% | +63.52% | +143.89% | 301B | |
| +0.85% | -1.22% | -17.60% | -0.51% | -4.35% | -45.36% | -36.90% | +33.49% | +83.81% | 217B | |
| +0.82% | -1.76% | +11.74% | +9.64% | +12.80% | +26.80% | +57.63% | +58.56% | +150.89% | 199B | |
| +2.09% | +2.18% | +24.07% | +23.96% | +26.27% | +48.90% | +85.85% | +139.17% | +70.03% | 192B | |
| +0.40% | +1.96% | +7.52% | +10.06% | +10.76% | +8.03% | -35.79% | -20.50% | -7.48% | 157B | |
| +5.69% | +4.37% | +11.35% | +12.43% | +8.41% | +7.07% | +68.29% | +133.73% | +475.69% | 125B | |
| +1.47% | -0.05% | +9.92% | +30.20% | +12.61% | +12.69% | -14.27% | +2.26% | -2.32% | 124B | |
| +0.45% | -5.49% | -1.65% | -13.57% | -6.08% | -25.33% | -12.81% | -1.38% | +9.64% | 111B | |
| -1.21% | +0.48% | +11.12% | +13.03% | +11.25% | +26.47% | +156.72% | +73.90% | +718.75% | 99.53B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +0.40% | +0.96% | +9.54% | +25.07% | +14.93% | +33.87% | +32.75% | +49.95% | +1.74% | 56.96B | |
| -0.87% | +1.36% | -5.99% | -7.42% | -2.25% | +27.98% | +32.98% | -36.01% | +308.95% | 55.99B | |
| +1.28% | +0.55% | +4.56% | +66.13% | +25.44% | +116.99% | -21.47% | -14.00% | -52.48% | 53.5B | |
| Average | +0.98% | +1.02% | +7.56% | +16.24% | +10.58% | +27.77% | +43.52% | +67.31% | +215.34% | 240.46B | |
| Weighted average by Cap. | +0.86% | +1.18% | +6.94% | +13.82% | +8.71% | +27.50% | +72.90% | +127.27% | +383.01% |
- Stock Market
- Equities
- GSK Stock
- Sector GSK plc
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition